AMSTERDAM, July 29 /PRNewswire/ --

- Database Now Offers Early Access to Research From 3000 Journals

Scopus(R), the world's largest abstract and citation database of
peer-reviewed literature, today announced that it has added
"Articles-in-Press" (AiP), abstracts of accepted research papers published
prior to being printed, from journals produced by Karger Medical and
Scientific Publishers, and Nature Publishing Group (NPG). In the fall, AiPs
from BioMed Central and IEEE will also be available. Scopus 
(http://www.info.scopus.com) previously offered access to AiPs from Elsevier
and Springer that included 2500 titles. This number will now rise to
approximately 3000.

Scopus AiP abstracts are citable and precede the final published, printed
version by up-to-four months, significantly accelerating the knowledge
discovery process for researchers. Researchers will gain access to the
full-text by linking from Scopus to the publishers' digital library. This
early access provides greater connectivity to the current state of research
in a range of fields, as well as a more timely method for evaluating the
output of authors and institutions. Since AiPs are posted online either as an
accepted manuscript or online publication (according to each publisher's
release policy), they may still be subject to changes and/or corrections by
the author or publisher. Scopus clearly labels AiPs as such so researchers
are aware that an updated abstract will be made available once the papers are
in print.

"Pre-print articles are extremely helpful in my work as a practitioner,"
comments Mark Levy, Senior Clinical Research Fellow for the Allergy &
Respiratory Research Group at the University of Edinburgh. "I need to be sure
I have access to the latest research that is relevant to my patients' needs
and treatment plans."

"Gaining access to the research pipeline can have an enormous impact,"
explains Niels Weertman, Director Scopus and Scirus. "It can open the door
for researchers to new ideas and collaboration partners, speeding the
advancement of science and in the medical community it can quite literally be
a matter of life and death."

About Scopus

Covering the world's research literature, Scopus is the largest abstract 
and citation database of peer-reviewed literature and quality Web sources 
with smart tools to track, analyze and visualize research. Scopus was 
designed and developed with over 500 users and librarians internationally. 
Its unique database contains abstracts and references from over 15,000 
peer-reviewed journals from 4,000 publishers worldwide, ensuring broad 
interdisciplinary coverage. In addition, Scopus not only offers users 
citation information about the articles covered, but also directly 
integrates Web and patent searches. Direct links to full-text articles, 
library resources and other applications like reference management software, 
make Scopus quicker, easier and more comprehensive to use than any other 
literature research tool. For more information about Scopus please visit 
http://www.info.scopus.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and 
medical information products and services. Working in partnership with the 
global science and health communities, Elsevier's 7,000 employees in over 70 
offices worldwide publish more than 2,000 journals and 1,900 new books per 
year, in addition to offering a suite of innovative electronic products, such 
as ScienceDirect (http://www.sciencedirect.com/), MD Consult 
(http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/),
bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in
Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of
Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading
publisher and information provider. Operating in the science and medical,
legal, education and business-to-business sectors, Reed Elsevier provides
high-quality and flexible information solutions to users, with increasing
emphasis on the Internet as a means of delivery. Reed Elsevier's ticker
symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).

CONTACT:

    Malkie Bernheim
    Padilla Speer Beardsley
    +1-212-752-8338 ext. 662
    mbernheim@psbpr.com